| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $124.5M | +0.9% | +4.7% |
| Cost of Revenue | $18.4M | -3.4% | -9.4% |
| Gross Profit | $106.2M | +1.7% | +7.6% |
| R&D Expense | $29.4M | -4.8% | -14.2% |
| SG&A Expense | $24.4M | -4.4% | -4.2% |
| Operating Income | $8.1M | +126.6% | +178.5% |
| Pre-tax Income | $11.7M | +55.4% | +316.7% |
| Income Tax | -$149.7M | -7925.4% | — |
| Net Income | $161.6M | +1587.6% | +2827.7% |
| EPS (Basic) | $1.72 | +1463.6% | +2557.1% |
| EPS (Diluted) | $1.69 | +1590.0% | +2514.3% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $324.3M | -4.5% | -0.7% |
| Short-term Investments | $223.5M | -2.0% | +3.6% |
| Accounts Receivable | $78.9M | +12.0% | +4.9% |
| Current Assets | $658.9M | -1.9% | +0.7% |
| Total Assets | $1.03B | +15.3% | +18.6% |
| Current Liabilities | $278.1M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $89.4M | — | — |
| Capital Expenditures | $2.1M | — | — |
| Investing Cash Flow | -$7.0M | — | — |
| Financing Cash Flow | -$105.4M | — | — |
| Free Cash Flow | $87.4M | — | — |
| -16.3% |
| Total Liabilities | $688.4M | -0.8% | -6.8% |
| Stockholders' Equity | $320.5M | +77.4% | +187.2% |